Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:582-589, 2006
DOI: 10.2337/diabetes.55.03.06.db05-0839
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duvillié, B.
Right arrow Articles by Scharfmann, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duvillié, B.
Right arrow Articles by Scharfmann, R.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Islet Study

The Mesenchyme Controls the Timing of Pancreatic ß-Cell Differentiation

Bertrand Duvillié1, Myriam Attali1, Ali Bounacer1, Philippe Ravassard2, Annie Basmaciogullari1, and Raphael Scharfmann1

1 Université Paris-Descartes, Faculté de Médecine, Institut National de la Santé et de la Recherche Médicale, E363, Hôpital Necker, Paris, France
2 Centre National de la Recherche Scientifique UMR7091, Hôpital Pitié Salpêtrière, Paris, France

Address correspondence and reprint requests to Bertrand Duvillié, Institut National de la Santé et de la Recherche Médicale, E363 Faculté Necker, 156 Rue de Vaugirard, 75015 Paris, France. E-mail: duvillie{at}necker.fr

Abbreviations: EGF, epidermal growth factor; FGF, fibroblast growth factor; Hes, Hairy and Enhancer-of-Split family; Ngn3, neurogenin3

The importance of mesenchymal-epithelial interactions in the proliferation of pancreatic progenitor cells is well established. Here, we provide evidence that the mesenchyme also controls the timing of ß-cell differentiation. When rat embryonic pancreatic epithelium was cultured without mesenchyme, we found first rapid induction in epithelial progenitor cells of the transcription factor neurogenin3 (Ngn3), a master gene controlling endocrine cell-fate decisions in progenitor cells; then ß-cell differentiation occurred. In the presence of mesenchyme, Ngn3 induction was delayed, and few ß-cells developed. This effect of the mesenchyme on Ngn3 induction was mediated by cell-cell contacts and required a functional Notch pathway. We then showed that associating Ngn3-expressing epithelial cells with mesenchyme resulted in poor ß-cell development via a mechanism mediated by soluble factors. Thus, in addition to its effect upstream of Ngn3, the mesenchyme regulated ß-cell differentiation downstream of Ngn3. In conclusion, these data indicate that the mesenchyme controls the timing of ß-cell differentiation both upstream and downstream of Ngn3.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
S. Cauchi, D. Meyre, C. Dina, H. Choquet, C. Samson, S. Gallina, B. Balkau, G. Charpentier, F. Pattou, V. Stetsyuk, et al.
Transcription Factor TCF7L2 Genetic Study in the French Population: Expression in Human {beta}-Cells and Adipose Tissue and Strong Association With Type 2 Diabetes.
Diabetes, October 1, 2006; 55(10): 2903 - 2908.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.